Related Experiment Video

Updated: May 10, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

RAS signaling pathways, mutations and their role in colorectal cancer

Kypros Zenonos1, Katy Kyprianou

  • 1Kypros Zenonos, Katy Kyprianou, College of Medical and Dental Sciences, University of Birmingham, Edgbaston B15 2TT, United Kingdom.

World Journal of Gastrointestinal Oncology
|June 27, 2013
PubMed

Insights

RAS proteins regulate crucial cell growth pathways like MAPK and PI3K. This review examines RAS mutations in cancer, focusing on their role in colorectal cancer progression and treatment response.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Cancer genetics

Background:

  • RAS proteins are key regulators of cellular signaling pathways, including mitogen-activated protein kinases (MAPK) and phosphoinositide-3 kinase (PI3K).
  • These pathways are vital for normal cell functions such as growth and survival.
  • Dysregulation of MAPK and PI3K pathways is a hallmark of malignant cells.

Purpose of the Study:

  • To review the role of RAS protein and associated mutations in cellular signaling pathways.
  • To explore the significance of RAS signaling in colorectal cancer (CRC) progression.
  • To discuss the impact of RAS and related mutations on treatment response and prognosis in CRC.

Main Methods:

  • Literature review of studies focusing on RAS signaling pathways.
  • Analysis of genetic mutations within RAS, MAPK, and PI3K pathways.
  • Examination of clinical data linking RAS mutations to colorectal cancer outcomes.

Main Results:

  • Mutations in RAS, MAPK, and PI3K pathways disrupt normal cellular functions, contributing to malignancy.
  • RAS signaling plays a critical role in the progression of colorectal cancer.
  • Specific RAS mutations are associated with altered treatment responses and prognoses in CRC patients.

Conclusions:

  • Understanding RAS pathway dysregulation is crucial for comprehending cancer development.
  • Targeting RAS signaling pathways presents potential therapeutic strategies for colorectal cancer.
  • RAS mutation status is an important biomarker for predicting treatment efficacy and patient outcomes in CRC.
Keywords:
Colorectal neoplasmsGenesMitogen-activated protein kinase signaling systemRASTherapeutics

More Related Videos

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...